Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two yearsCNBC • 01/02/24
Midday Movers: Moderna Rises After an Upgrade, While Apple Falls Following DowngradeInvestopedia • 01/02/24
Moderna's stock soars 10% to lead S&P 500 gainers as Oppenheimer upgrades to buyMarket Watch • 01/02/24
Is Moderna Stock A Buy After Retaking Its 50-Day Line On Strong Cancer Vaccine Sales?Investors Business Daily • 12/19/23
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024The Motley Fool • 12/18/23